MedPath

Hematoma Block for Reduction of Distal Radius Fractures

Phase 4
Completed
Conditions
Fractures of the Distal Radius
Interventions
Registration Number
NCT02129270
Lead Sponsor
HaEmek Medical Center, Israel
Brief Summary

The purpose of this study is to Prove that injection of 15 to 20 mL of lidocaine 1% into the fracture site (Hematoma block) is more effective in terms of pain relieving then injection of 10 mL of lidocaine 2%, and equally safe in terms of complications, for closed reduction of distal radius fractures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Patients with Fractures of the distal radius, with or without ulna fracture
Exclusion Criteria
  • Children,
  • pregnant women,
  • patients with infection or suspected infection on the site for injection.
  • Patients whose condition requires general anesthesia (patients with more fractures other than the distal radius and ulna, patients with many damage...)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Lidocaine HCl 1%Lidocaine HCl 1%Lidocaine HCl 1% (100mg/10ml) 15-20 ml.
Lidocaine HCl 2%Lidocaine HCl 2% .Lidocaine HCl 2% (200mg/10ml) 10 ml.
Primary Outcome Measures
NameTimeMethod
This study will be measured effective in terms of pain relieving with Visual Analog Scale.1 year
Secondary Outcome Measures
NameTimeMethod
This study will be measured safe in terms of complications to injection.1 year

Number of Participants with Adverse Events as a Measure of Safety and Tolerability.

Trial Locations

Locations (1)

HaEmek medical center

🇮🇱

Afula, Israel

© Copyright 2025. All Rights Reserved by MedPath